Studies found that neurological damage and cognitive impairment were accompanied by the downregulated AMPK/Nrf2 pathway (Cao et al., 2020), suggesting that the SIRT3/AMPK/Nrf2 pathway may be a target for the treatment of PND. Here, NFE2L2 is linked to Cognitive impairment.